News | December 10, 2023
Aptar Pharms opens new production facility at Taloja, Mumbai
New facility is part of Aptar Pharma’s global expansion program
New facility is part of Aptar Pharma’s global expansion program
Multi-ethnic innovation helps all complexions appear clearer and more uniform
The divestment is a part of Fortis' ongoing portfolio rationalization strategy
Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
XTANDI becomes the first and only androgen receptor signaling inhibitor approved for use with or without a GnRH analog therapy in nonmetastatic castration-sensitive prostate cancer
Merck to pay Daiichi Sankyo a $4 billion upfront payment in addition to $1.5 billion in continuation payments over the next 24 months
Alignment of carbon-fiber can be controlled during the 3D printing process
Dozee Pro Ex will offer Ambulatory patient monitoring for a seamless continuum of patient monitoring across different care settings
The first phase of the hospital with 225 beds built over 1.75 lakh square feet will be commissioned in the next 12 months
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
Subscribe To Our Newsletter & Stay Updated
